Position in DHR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$322,292
-$294,476 QoQ
Shares Held
1,692
-48.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,564
of 2,098 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Harfst & Associates, Inc. holds $2,311,688 across 2 Diagnostics & Research names. DHR ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,968 | $1,989,396 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,692 | $322,292 |
All Filings in DHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,292 | 1,692 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $616,768 | 3,253 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,859,288 | 8,122 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,616,017 | 8,151 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,582,295 | 8,010 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $676,090 | 3,298 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||